Submental aesthetics · 520 nm green + 405 nm violet
CLX Laser
A precise, non-thermal approach to the under-chin area
Overview
About the CLX Laser
CLX pairs 520 nm green and 405 nm violet wavelengths in a touchless, non-thermal platform for non-invasive aesthetic treatment to improve the appearance of the submental (under-chin) area. Treatment is delivered without contact or therapeutic heating, with 15-minute sessions and no procedural downtime.
- 520 nm green and 405 nm violet wavelengths
- Touchless, non-thermal treatment
- Eight 15-minute sessions over four weeks
- No needles, incisions or per-session consumables
Typical applications
- Non-invasive aesthetic improvement of the submental (under-chin) area
- Aesthetic practices and medically supervised facial aesthetics
- A focused addition to a body-contouring clinic's services
Our fat-loss lasers have been featured in
Product description
What the device does
CLX is a focused aesthetic platform for the submental area. Patients rest comfortably while the device operates, without needles, incisions, anaesthesia or therapeutic heating. Erchonia describes the protocol as eight 15-minute, non-contact sessions delivered over four weeks.
The hands-free approach offers a streamlined service for aesthetic practices, facial aesthetics and body-contouring clinics. There are no applicator cards, gels, syringes or consumable kits to restock for each session.
Unlike a full-body circumference-reduction platform, CLX is focused on improving the appearance of the under-chin area. Suitability and treatment planning should be assessed by a medical professional.
Mechanism
How it works
CLX delivers specific green and violet wavelengths through a non-contact, non-thermal approach. Erchonia describes the technology in terms of the energy carried by each photon and the biological response to an appropriate light dose, rather than wattage and heat.
In the clinical study, the mechanism is described as stimulating adipocytes to release stored lipid content without destroying the cells. Released lipids are processed naturally by the body, with the appearance of the submental area changing over the treatment course.
Patients rest during each 15-minute session and can return to their day without procedural downtime. Individual results vary.
FDA indications for use
Clearance K252574
- a.Non-invasive aesthetic treatment to improve the appearance of the submental (under-chin) area.
Device intended for medical professionals. Prescription use (21 CFR 801 Subpart D). Individual results may vary.
Specifications
At a glance
Wavelengths
520 nm green & 405 nm violet
Treatment area
Submental (under-chin) area
Delivery
Non-contact, hands-free
Thermal profile
Non-thermal; no therapeutic heating
Session length
15 minutes
Study protocol
8 sessions over 4 weeks
Procedural downtime
None
Per-session consumables
No applicator cards, gels or consumable kits
Use
Prescription use; medical professionals
Clinical evidence
Eight sessions. Blinded review.
Erchonia reports a prospective, dual-centre study in adults with measurable submental fat. Participants received eight 15-minute treatments over four weeks. Three independent, board-certified cosmetic surgeons assessed photographs in a blinded review.
- 86.7%
- Blinded-review success on an intent-to-treat basis — and 95.8% correct identification of the post-treatment photograph at the 12-week follow-up.
- 5.45 mm
- Mean reduction in submental skinfold thickness, with BMI stable — the change is under the chin, not on the scale.
- 92%
- Patient satisfaction at 12 weeks, with zero device-related adverse events.
Intent-to-treat: 86.7%; per-protocol at 12 weeks: 95.8%. Erchonia CLX dual-centre clinical study.
Erchonia CLX dual-centre clinical study. Individual results vary.
Erchonia CLX dual-centre clinical study.
Manufacturer-reported study outcomes, not guaranteed results. Individual results vary. US FDA clearance does not establish Australian regulatory status.
Read Erchonia’s CLX clinical study summaryCompare
How to choose the right device for your clinic
Every laser in the Erchonia portfolio is a valuable addition. This matrix compares format, wavelength and FDA-cleared indication across the range.
| Choosing the right device | ||||||
|---|---|---|---|---|---|---|
| Collimated, monochromatic, coherent true laser | Yes | Yes | Yes | Yes | Yes | Yes |
| Non-thermal — no heat, pain or downtime | Yes | Yes | Yes | Yes | Yes | Yes |
| Short 10–30 minute treatments | Yes | Yes | Yes | Yes | Yes | Yes |
| Handheld and portable | Not specified | No | Yes | Yes | No | No |
| Automated — hands-free during treatment | Yes | Yes | No | No | Yes | Yes |
| Green wavelength (520–542 nm) | Yes | Yes | Yes | No | No | No |
| Red wavelength (640 nm) | No | No | No | Yes | Yes | Yes |
| Violet wavelength (405 nm) | Yes | No | Yes | Yes | Yes | Yes |
| Musculoskeletal pain indication | No | No | Yes | Yes | Yes | No |
| Dermatological / acne indication | No | No | Yes | Yes | No | No |
| Body circumference reduction indication | No | Yes | No | No | No | No |
| Onychomycosis (clear nail growth) indication | No | No | No | No | No | Yes |
| Post-operative pain indication | No | No | No | No | Yes | No |
| FDA market cleared, ISO/IEC compliant | Not specified | Yes | Yes | Yes | Yes | Yes |
| Submental (under-chin) aesthetic indication | Yes | No | No | No | No | No |
Enquire
Enquire about the CLX Laser
Tell us about your practice and we'll arrange the right next step — demonstration, pricing or training.
Experience the Erchonia range in your clinic
Book a private demonstration with the Erchonia Lasers Australia team, or find your nearest treating clinic.